abstract Objectives To perform a systematic review of neurologic involvement in Systemic
sclerosis (SSc) and Localized Scleroderma (LS), describing clinical features, neuroimaging …

Objective A number of studies (all n< 200) have assessed health‐related quality of life
(HRQOL) in patients with systemic sclerosis (SSc), but no systematic review of the effect of …

Systemic sclerosis (SSc) is a chronic multi-system autoimmune disease associated with
disability and reduced quality of life. There is no effective treatment or cure to SSc, so it is …

Objective: To assess the impact of digital ulcers (DUs) on disability and health-related
quality of life (HRQoL) in systemic sclerosis (SSc). Methods: Two hundred and thirteen …

A lively topic of debate in decision theory over recent years concerns our understanding of
the different risk attitudes exhibited by decision makers. There is ample evidence that risk …

Objectives Our aim was to describe the burden of early dcSSc in terms of disability, fatigue
and pain in the European Scleroderma Observational Study cohort, and to explore …

Is coping with illness really a matter of agency? Drawing on ethnographic research among
people with rheumatological and neurological chronic diseases in the United States, I argue …

Abstract Objective. Short Form-36 (SF-36) is a validated outcome measure to assess health-
related quality of life (HRQOL) in patients with gout. We assessed responsiveness to change …

Objectives. SSc-associated gastrointestinal tract involvement (SSc-GIT) is an important
predictor of depressive symptoms. University of California at Los Angeles Scleroderma …

Background Cost-utility models are frequently used to compare treatments intended to
prevent or delay the onset of cardiovascular events. Most published utilities represent post …